![Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores](https://www.mdpi.com/cancers/cancers-13-00844/article_deploy/html/images/cancers-13-00844-g003.png)
Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
![Breast cancer test could predict chances of disease's return 20 years later, study shows | The Independent | The Independent Breast cancer test could predict chances of disease's return 20 years later, study shows | The Independent | The Independent](https://static.independent.co.uk/s3fs-public/thumbnails/image/2018/05/02/22/pa-3649262.jpg)
Breast cancer test could predict chances of disease's return 20 years later, study shows | The Independent | The Independent
![Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool - ScienceDirect Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980492200380X-gr1.jpg)
Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool - ScienceDirect
![Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia](https://www.mdpi.com/cancers/cancers-15-02064/article_deploy/html/images/cancers-15-02064-g001.png)
Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia
![Web calculator showing survival estimates for clinical example 1, 12... | Download Scientific Diagram Web calculator showing survival estimates for clinical example 1, 12... | Download Scientific Diagram](https://www.researchgate.net/publication/317607599/figure/fig3/AS:614313379233792@1523475131063/Web-calculator-showing-survival-estimates-for-clinical-example-1-12-months-after_Q320.jpg)
Web calculator showing survival estimates for clinical example 1, 12... | Download Scientific Diagram
![Simple online calculator helps women determine their risk of breast cancer | The Independent | The Independent Simple online calculator helps women determine their risk of breast cancer | The Independent | The Independent](https://static.independent.co.uk/s3fs-public/thumbnails/image/2015/10/01/22/cancercalculator.gif)
Simple online calculator helps women determine their risk of breast cancer | The Independent | The Independent
![Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review](https://www.mdpi.com/cancers/cancers-14-01898/article_deploy/html/images/cancers-14-01898-g001.png)
Cancers | Free Full-Text | Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
![A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-61535-9/MediaObjects/41598_2020_61535_Fig1_HTML.png)
A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports
![Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00288-8/MediaObjects/41523_2021_288_Fig1_HTML.png)
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer
![Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy](https://www.mdpi.com/cancers/cancers-14-03848/article_deploy/html/images/cancers-14-03848-g001.png)
Cancers | Free Full-Text | Multimodal Prediction of Five-Year Breast Cancer Recurrence in Women Who Receive Neoadjuvant Chemotherapy
![A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S096097762101002X-gr1.jpg)
A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/aebe7284-f489-4fa5-a13d-db5ed5bcba73/gr2_lrg.jpg)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Pulsus Journal of Surgical Research Using CTS5 Calculator to predict the 5-10 risk of recurrence and to reduce the number of pat
![A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-61535-9/MediaObjects/41598_2020_61535_Fig3_HTML.png)
A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports
![PDF) A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer PDF) A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer](https://i1.rgstatic.net/publication/272192765_A_preoperative_nomogram_to_predict_the_risk_of_synchronous_distant_metastases_at_diagnosis_of_primary_breast_cancer/links/574b5f0c08ae5c51e29ea959/largepreview.png)